Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice

Nov-20

Pharmacoepidemiology

AUTHORS : Dr Luis A. García Rodríguez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: lagarcia@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : Expert Opinion on Drug Safety

REFERENCE: 19(11):1513-1520

DOI : 10.1080/14740338.2020.1798928

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more